Sulphated heparan sulfated for inhibiting cell proliferation
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHENZHEN HEPALINK PHARMA GRP CO LTD
- Publication Date
- 2013-09-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a sulfated heparan sulfate (Heparan Sulfated, HS), its preparation method and its application in inhibiting cell proliferation. Background technique
[0002] HS is a complex polysaccharide compound widely present on the cell surface and in the extracellular matrix (ECM). Its structure is as figure 1 [Sanaullah Khan, Elizabeth Rodriguez, Rima Patel, Jayesh Gor, Barbara Mulloy, Stephen J. Perkins. The Solution Structure of Heparan Sulfate Differs from That of Heparin. J Biol Chem. 2011, 286(28): 24842–24854], of which Glucosamine residues can be modified by N-acetylation, N- and O-sulfation, and glucuronic acid residues can be isomerized to iduronic acid (IdoA) residues.
[0003] Tumor invasion and metastasis are the most dangerous stages in the process of tumor occurrence and evolution, and they are also signs of malignant development of tumors. More than 80% of clinical cancer patients die from tumor invasion and metastasis. ...